rss
J Med Genet 2004;41:273-277 doi:10.1136/jmg.2003.014787
  • Short report

Homozygosity mapping of a third Joubert syndrome locus to 6q23

  1. C Lagier-Tourenne1,
  2. E Boltshauser2,
  3. N Breivik3,
  4. M Gribaa1,
  5. C Bétard4,
  6. C Barbot5,
  7. M Koenig1
  1. 1IGBMC, CNRS/INSERM/ULP, Illkirch, C.U. de Strasbourg, France
  2. 2Department of Neurology, Children’s University Hospital, Zürich, Switzerland
  3. 3Department of Paediatrics, Aalesund Hospital, Aalesund, Norway
  4. 4Centre National de Génotypage, Evry, France
  5. 5Department of Neurology, Hospital Maria Pia, Porto, Portugal
  1. Correspondence to:
 Professor M Koenig
 Institut de Génétique et de Biologie Moléculaire et Cellulaire, 1 rue Laurent Fries BP10142, 67404 Illkirch cedex, C.U. de Strasbourg, France; mkoenigigbmc.u-strasbg.fr
  • Received 1 January 2004
  • Accepted 6 January 2004

Abstract

Background: Joubert syndrome (JS) is a recessively inherited disorder characterised by hypotonia at birth and developmental delay, followed by truncal ataxia and cognitive impairment, characteristic neuroimaging findings (cerebellar vermis hypoplasia, “molar tooth sign”) and suggestive facial features. JS is clinically heterogeneous with some patients presenting with breathing abnormalities in the neonatal period, oculomotor apraxia, retinal dystrophy, retinal coloboma, ptosis, hexadactyly, and nephronophtisis or cystic dysplastic kidneys. JS is also genetically heterogeneous, with two known loci, on 9q34 (JBTS1) and 11p11-q12 (CORS2), representing only a fraction of cases.

Methods: A large consanguineous Joubert family (five affected) was analysed for linkage with a marker set covering the entire genome and 16 smaller families were subsequently tested for candidate loci.

Results: We report here the identification of a third locus in 6q23 (JBTS3) from the study of two consanguineous families. LOD score calculation, including the consanguinity loops, gave a maximum value of 4.1 and 2.3 at q = 0 for the two families, respectively.

Conclusions: Linkage between the disease and the D6S1620–D6S1699 haplotype spanning a 13.1 cM interval is demonstrated. Genotype-phenotype studies indicate that, unlike CORS2, JBTS3 appears not to be associated with renal dysfunction.

Footnotes

  • Genetic studies were supported by funds from the Institut National de la Santé et de la Recherche Médicale, the Centre National de la Recherche Scientifique, the Hôpitaux Universitaires de Strasbourg (PHRC régional), and the GIS-Maladies Rares. CL-T was supported by the Fondation pour la Recherche Médicale and by the Association Française contre les Myopathies.

  • Conflict of interest: none declared.

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JMG.
View free sample issue >>

Free archive
The full back archive is now available for JMG. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • Latest genetics jobs

    Latest genetics jobs